FDA Wants To Fully Approve Pfizer Vaccine By Early September: Report
HuffPost
Full approval is expected to give a boost to vaccine mandates around the country.
The U.S. Food and Drug Administration is aiming to grant full approval to Pfizer-BioNTech’s COVID-19 vaccine by early next month, according to a New York Times report published Wednesday that cited unnamed people familiar with the decision-making process. The Pfizer drug was the first in the country to be granted emergency use authorization from the FDA, which it received in early December. It filed for full approval ― called a biologics license application ― with the agency in early May. The FDA requires drug manufacturers to secure more data in order to obtain a biologics license instead of an emergency use authorization.More Related News